BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

570 related articles for article (PubMed ID: 16995822)

  • 1. Surveillance for early detection of aggressive parathyroid disease: carcinoma and atypical adenoma in familial isolated hyperparathyroidism associated with a germline HRPT2 mutation.
    Kelly TG; Shattuck TM; Reyes-Mugica M; Stewart AF; Simonds WF; Udelsman R; Arnold A; Carpenter TO
    J Bone Miner Res; 2006 Oct; 21(10):1666-71. PubMed ID: 16995822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic analyses in patients with familial isolated hyperparathyroidism and hyperparathyroidism-jaw tumour syndrome.
    Mizusawa N; Uchino S; Iwata T; Tsuyuguchi M; Suzuki Y; Mizukoshi T; Yamashita Y; Sakurai A; Suzuki S; Beniko M; Tahara H; Fujisawa M; Kamata N; Fujisawa K; Yashiro T; Nagao D; Golam HM; Sano T; Noguchi S; Yoshimoto K
    Clin Endocrinol (Oxf); 2006 Jul; 65(1):9-16. PubMed ID: 16817812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic analyses in familial isolated hyperparathyroidism: implication for clinical assessment and surgical management.
    Cetani F; Pardi E; Ambrogini E; Lemmi M; Borsari S; Cianferotti L; Vignali E; Viacava P; Berti P; Mariotti S; Pinchera A; Marcocci C
    Clin Endocrinol (Oxf); 2006 Feb; 64(2):146-52. PubMed ID: 16430712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hyperparathyroidism-jaw tumor syndrome. A hereditary form of primary hyperparathyroidism with parathyroid carcinoma].
    Raue F; Haag Ch; Frank-Raue K
    Dtsch Med Wochenschr; 2007 Jul; 132(27):1459-62. PubMed ID: 17583828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different somatic alterations of the HRPT2 gene in a patient with recurrent sporadic primary hyperparathyroidism carrying an HRPT2 germline mutation.
    Cetani F; Pardi E; Ambrogini E; Viacava P; Borsari S; Lemmi M; Cianferotti L; Miccoli P; Pinchera A; Arnold A; Marcocci C
    Endocr Relat Cancer; 2007 Jun; 14(2):493-9. PubMed ID: 17639062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of parathyroid tumors in familial isolated hyperparathyroidism with HRPT2 mutation: implications for cancer surveillance.
    Guarnieri V; Scillitani A; Muscarella LA; Battista C; Bonfitto N; Bisceglia M; Minisola S; Mascia ML; D'Agruma L; Cole DE
    J Clin Endocrinol Metab; 2006 Aug; 91(8):2827-32. PubMed ID: 16720667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical, genetic, and histopathologic investigation of CDC73-related familial hyperparathyroidism.
    Masi G; Barzon L; Iacobone M; Viel G; Porzionato A; Macchi V; De Caro R; Favia G; Palù G
    Endocr Relat Cancer; 2008 Dec; 15(4):1115-26. PubMed ID: 18755853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma.
    Shattuck TM; Välimäki S; Obara T; Gaz RD; Clark OH; Shoback D; Wierman ME; Tojo K; Robbins CM; Carpten JD; Farnebo LO; Larsson C; Arnold A
    N Engl J Med; 2003 Oct; 349(18):1722-9. PubMed ID: 14585940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial hyperparathyroidism: surgical outcome after 30 years of follow-up in three families with germline HRPT2 mutations.
    Sarquis MS; Silveira LG; Pimenta FJ; Dias EP; Teh BT; Friedman E; Gomez RS; Tavares GC; Eng C; De Marco L
    Surgery; 2008 May; 143(5):630-40. PubMed ID: 18436011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic analyses of the HRPT2 gene in primary hyperparathyroidism: germline and somatic mutations in familial and sporadic parathyroid tumors.
    Cetani F; Pardi E; Borsari S; Viacava P; Dipollina G; Cianferotti L; Ambrogini E; Gazzerro E; Colussi G; Berti P; Miccoli P; Pinchera A; Marcocci C
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5583-91. PubMed ID: 15531515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDC73/HRPT2 CpG island hypermethylation and mutation of 5'-untranslated sequence are uncommon mechanisms of silencing parafibromin in parathyroid tumors.
    Hahn MA; Howell VM; Gill AJ; Clarkson A; Weaire-Buchanan G; Robinson BG; Delbridge L; Gimm O; Schmitt WD; Teh BT; Marsh DJ
    Endocr Relat Cancer; 2010 Mar; 17(1):273-82. PubMed ID: 20026646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the first germline HRPT2 whole-gene deletion in a patient with primary hyperparathyroidism.
    Domingues R; Tomaz RA; Martins C; Nunes C; Bugalho MJ; Cavaco BM
    Clin Endocrinol (Oxf); 2012 Jan; 76(1):33-8. PubMed ID: 21790700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor suppressor gene mutation in a patient with a history of hyperparathyroidism-jaw tumor syndrome and healed generalized osteitis fibrosa cystica: a case report and genetic pathophysiology review.
    Parfitt J; Harris M; Wright JM; Kalamchi S
    J Oral Maxillofac Surg; 2015 Jan; 73(1):194.e1-9. PubMed ID: 25511968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial isolated primary hyperparathyroidism/hyperparathyroidism-jaw tumour syndrome caused by germline gross deletion or point mutations of CDC73 gene in Chinese.
    Kong J; Wang O; Nie M; Shi J; Hu Y; Jiang Y; Li M; Xia W; Meng X; Xing X
    Clin Endocrinol (Oxf); 2014 Aug; 81(2):222-30. PubMed ID: 24716902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid mutation screening for HRPT2 and MEN1 mutations associated with familial and sporadic primary hyperparathyroidism.
    Howell VM; Cardinal JW; Richardson AL; Gimm O; Robinson BG; Marsh DJ
    J Mol Diagn; 2006 Nov; 8(5):559-66. PubMed ID: 17065424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent large germline HRPT2 deletions in a French National cohort of patients with primary hyperparathyroidism.
    Bricaire L; Odou MF; Cardot-Bauters C; Delemer B; North MO; Salenave S; Vezzosi D; Kuhn JM; Murat A; Caron P; Sadoul JL; Silve C; Chanson P; Barlier A; Clauser E; Porchet N; Groussin L;
    J Clin Endocrinol Metab; 2013 Feb; 98(2):E403-8. PubMed ID: 23293331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of the first gross CDC73 germline deletion in an HPT-JT syndrome family.
    Cascón A; Huarte-Mendicoa CV; Javier Leandro-García L; Letón R; Suela J; Santana A; Costa MB; Comino-Méndez I; Landa I; Sánchez L; Rodríguez-Antona C; Cigudosa JC; Robledo M
    Genes Chromosomes Cancer; 2011 Nov; 50(11):922-9. PubMed ID: 21837707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re: Familial hyperparathyroidism: surgical outcome after 30 years of follow-up in three families with germline HRPT2 mutations.
    Guarnieri V; Bisceglia M; Bonfitto N; Cetani F; Marcocci C; Minisola S; Battista C; Chiodini I; Cole DE; Scillitani A
    Surgery; 2008 Nov; 144(5):839-40. PubMed ID: 19081034
    [No Abstract]   [Full Text] [Related]  

  • 19. A case of hyperparathyroidism-jaw tumour syndrome found in the treatment of an ossifying fibroma in the maxillary bone.
    Yamashita Y; Akiyama T; Mizusawa N; Yoshimoto K; Goto M
    Int J Oral Maxillofac Surg; 2007 Apr; 36(4):365-9. PubMed ID: 17052894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperparathyroidism 2 gene (HRPT2, CDC73) and parafibromin studies in two patients with primary hyperparathyroidism and uncertain pathological assessment.
    Cetani F; Pardi E; Ambrogini E; Banti C; Viacava P; Borsari S; Bilezikian JP; Pinchera A; Marcocci C
    J Endocrinol Invest; 2008 Oct; 31(10):900-4. PubMed ID: 19092296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.